Andrew O'Connor is currently a Board Observer at kea, Robigo, GaeaStar, Daqus Energy, and Elementium Materials, Inc., and serves as Chairman of the Board at NanoPath. Previously, they held various roles, including VC Summer Associate at In-Q-Tel and COO at Alveolus Bio and ResBiotic. Andrew has a strong engineering background with experience as a Process Development Engineer at Midori USA, Inc. and Pulmatrix Inc. They are currently pursuing an MBA and a Master of Science in Engineering Sciences at Harvard, and have studied Biochemical and Chemical Engineering at Danmarks Tekniske Universitet, along with a Bachelor’s in Chemical Engineering from Auburn University. Passionate about technology's potential to improve lives, Andrew focuses on innovation and investment in early-stage technology companies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices